| Medical and Health Sciences | Lifetime | 128 | AT 1 | 99.99 |
| Biological Sciences | Lifetime | 140 | AT 1 | 99.98 |
| Clinical Neurology | Lifetime | 11 | AT 2 | 99.96 |
| Neuroscience of Neurology | Lifetime | 7 | AT 1 | 99.94 |
| Anatomy | Lifetime | 3 | AT 1 | 99.75 |
| Medical Physiology | Lifetime | 53 | AT 1 | 99.92 |
| Psychiatry and Mental health | Lifetime | 66 | AT 1 | 99.81 |
| Cellular and Molecular Neuroscience | Lifetime | 141 | AT 2 | 99.52 |
| Cognitive Neuroscience | Lifetime | 517 | AT 10 | 98.80 |
| Complementary and Alternative Medicine | Lifetime | 388 | AT 3 | 97.83 |
| Pathology and Forensic Medicine | Lifetime | 611 | AT 3 | 97.26 |
| Pediatrics, Perinatology and Child Health | Lifetime | 853 | AT 4 | 97.17 |
| Medical Genetics | Lifetime | 422 | AT 2 | 96.38 |
| Rheumatology | Lifetime | 762 | AT 10 | 96.09 |
| Clinical Biochemistry | Lifetime | 291 | AT 5 | 94.83 |
| Philosophy of Mind, Language and Cognitive Science | Lifetime | 510 | AT 5 | 93.32 |
| Rehabilitation | Lifetime | 800 | AT 3 | 81.45 |
| Developmental Neuroscience | Lifetime | 461 | AT 4 | 78.05 |
| Microbiology | Lifetime | 693 | AT 4 | 76.30 |
| Biological Psychiatry | Lifetime | 291 | AT 8 | 74.49 |
| Virology | Lifetime | 682 | AT 3 | 57.54 |
| Sensory Systems | Lifetime | 767 | AT 6 | 55.89 |
| Clinical Neurology | 2021-2025 | 71 | AT 2 | 98.45 |
| Medical Physiology | 2021-2025 | 234 | AT 1 | 96.88 |
| Neuroscience of Neurology | 2021-2025 | 121 | AT 1 | 93.68 |
| Psychiatry and Mental health | 2021-2025 | 196 | AT 2 | 95.93 |
| Cellular and Molecular Neuroscience | 2021-2025 | 171 | AT 3 | 87.02 |
| Pathology and Forensic Medicine | 2021-2025 | 480 | AT 5 | 77.59 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 11 | AT 2 | 99.93 |
| Neurological and metabolic disorders | Lifetime | 4 | AT 1 | 99.82 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 16 | AT 2 | 99.87 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 7 | AT 1 | 99.82 |
| Neurological diseases and metabolism | Lifetime | 7 | AT 1 | 99.84 |
| Alzheimer's disease research and treatments | Lifetime | 37 | AT 1 | 99.90 |
| Cerebrovascular and genetic disorders | Lifetime | 4 | AT 1 | 99.73 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 19 | AT 1 | 99.81 |
| Neurology and Historical Studies | Lifetime | 4 | AT 1 | 99.27 |
| Dementia and Cognitive Impairment Research | Lifetime | 48 | AT 1 | 99.82 |
| Medical and Biological Sciences | Lifetime | 20 | AT 2 | 99.32 |
| Genetic Neurodegenerative Diseases | Lifetime | 37 | AT 3 | 99.61 |
| RNA regulation and disease | Lifetime | 39 | AT 2 | 99.23 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 64 | AT 3 | 99.49 |
| Ginkgo biloba and Cashew Applications | Lifetime | 10 | AT 1 | 99.32 |
| Mitochondrial Function and Pathology | Lifetime | 191 | AT 1 | 99.19 |
| Cerebrospinal fluid and hydrocephalus | Lifetime | 88 | AT 1 | 98.87 |
| Nuclear Receptors and Signaling | Lifetime | 44 | AT 1 | 99.30 |
| Glioma Diagnosis and Treatment | Lifetime | 235 | AT 2 | 99.16 |
| Metabolism and Genetic Disorders | Lifetime | 277 | AT 5 | 98.85 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 86 | AT 2 | 99.09 |
| Infectious Encephalopathies and Encephalitis | Lifetime | 33 | AT 2 | 98.49 |
| Epilepsy research and treatment | Lifetime | 291 | AT 3 | 98.51 |
| Fetal and Pediatric Neurological Disorders | Lifetime | 154 | AT 2 | 98.32 |
| Traumatic Brain Injury and Neurovascular Disturbances | Lifetime | 526 | AT 5 | 98.48 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 45 | AT 1 | 96.12 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 650 | AT 6 | 97.94 |
| Alcoholism and Thiamine Deficiency | Lifetime | 106 | AT 1 | 96.64 |
| Hemispheric Asymmetry in Neuroscience | Lifetime | 76 | AT 1 | 96.48 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 433 | AT 1 | 96.89 |
| Management of metastatic bone disease | Lifetime | 290 | AT 6 | 96.62 |
| Brain Metastases and Treatment | Lifetime | 462 | AT 7 | 96.98 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 238 | AT 3 | 97.12 |
| Autism Spectrum Disorder Research | Lifetime | 874 | AT 2 | 96.29 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 360 | AT 1 | 96.16 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 235 | AT 3 | 95.93 |
| Traumatic Brain Injury Research | Lifetime | 672 | AT 2 | 95.55 |
| Prion Diseases and Protein Misfolding | Lifetime | 327 | AT 2 | 95.35 |
| Soft tissue tumor case studies | Lifetime | 380 | AT 3 | 95.12 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 636 | AT 6 | 94.70 |
| Neuroscience, Education and Cognitive Function | Lifetime | 129 | AT 6 | 93.68 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 120 | AT 3 | 94.36 |
| Biomedical and Chemical Research | Lifetime | 160 | AT 3 | 92.35 |
| Biotin and Related Studies | Lifetime | 364 | AT 5 | 92.85 |
| Ophthalmology and Eye Disorders | Lifetime | 895 | AT 5 | 93.89 |
| Migraine and Headache Studies | Lifetime | 846 | AT 8 | 92.06 |
| Paranormal Experiences and Beliefs | Lifetime | 107 | AT 2 | 90.51 |
| Plant and Biological Electrophysiology Studies | Lifetime | 338 | AT 3 | 90.61 |
| Medical Research and Practices | Lifetime | 43 | AT 1 | 86.84 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 531 | AT 9 | 88.51 |
| Restless Legs Syndrome Research | Lifetime | 473 | AT 16 | 89.06 |
| Neurological Complications and Syndromes | Lifetime | 954 | AT 7 | 87.72 |
| Teratomas and Epidermoid Cysts | Lifetime | 402 | AT 3 | 85.10 |
| Neuroethics, Human Enhancement, Biomedical Innovations | Lifetime | 318 | AT 3 | 85.13 |
| Spinal Hematomas and Complications | Lifetime | 846 | AT 4 | 82.03 |
| 14-3-3 protein interactions | Lifetime | 793 | AT 6 | 78.70 |
| Hallucinations in medical conditions | Lifetime | 470 | AT 2 | 52.49 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 77 | AT 3 | 98.56 |
| Neuromodulation and Treatments for Neurological Disorders | 2021-2025 | 103 | AT 2 | 97.83 |
| Alzheimer's disease research and treatments | 2021-2025 | 254 | AT 1 | 97.16 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 451 | AT 1 | 96.26 |
| Genetic Neurodegenerative Diseases | 2021-2025 | 275 | AT 9 | 91.49 |
| Amyotrophic Lateral Sclerosis Research | 2021-2025 | 385 | AT 1 | 87.11 |
| Botulinum Toxin and Related Neurological Disorders | 2021-2025 | 572 | AT 6 | 84.68 |
| Neurological diseases and metabolism | 2021-2025 | 264 | AT 5 | 80.33 |
| Transcranial Magnetic Stimulation Studies | 2021-2025 | 934 | AT 9 | 80.98 |
